PHILADELPHIA (May 27, 2025) — Fox Chase Cancer Center is pleased to announce the hiring of John C. Ruckdeschel, MD, FACP, FCCP, as a Professor in the Department of Hematology/Oncology.
Ruckdeschel joins Fox Chase with a wealth of experience. From 1991 to 2002 he was the inaugural CEO of the Moffitt Cancer Center in Tampa, Florida, and from 2002 to 2009 he served as CEO of the Karmanos Cancer Center in Detroit. He went on to leadership positions at the Nevada Cancer Institute in Las Vegas, Intermountain Health Care in Salt Lake City, and the University of Mississippi Medical Center’s Cancer Center and Research Institute.
From 2020 through 2023, he served as Chief Medical Officer and as a member of the advisory board for MetiStream Inc., a developer of healthcare analytics software. For many years, he has led a legal consulting firm that focuses on anti-tobacco related cases
Ruckdeschel earned his undergraduate degree in biology from Rensselaer Polytechnic Institute, where he remains a member of the advisory board for the School of Science, and his medical degree from Albany Medical College. He completed his medical training at Johns Hopkins Hospital in Baltimore, Beth Israel Hospital in Boston, and the National Cancer Institute.
Over the course of his career, Ruckdeschel has achieved multiple honors, including the Distinguished Johns Hopkins School of Medicine Alumni Award, the St. George Award from the American Cancer Society, and the Distinguished Southern Oncologist Award.
In addition to his role at Fox Chase, he currently holds positions as a board member of the Philadelphia Market Area of the American Cancer Society, chief medical officer for Multiverse Inc., and as a medical advisory board member of the Prevent Cancer Foundation. He also serves as associate editor of British Medical Journal Case Reports and an editor for the Cochrane Lung Cancer Review Group.
Ruckdeschel is a member of the American Medical Informatics Association, the American Cancer Society, the American Medical Association, the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, the American College of Physicians, the American College of Chest Physicians, and the American Association for Cancer Research.
Ruckdeschel has published over 150 peer-reviewed studies and has contributed to the publication of over 90 book chapters, letters, monographs, and symposia reports over the course of his career.